Long-Term NMDAR Antagonism Correlates Weight Loss With Less Eating
Memantine hydrochloride is an uncompetitive N-methyl-D-aspartate (NMDA) antagonist for treatment of moderate-to-severe Alzheimer's disease. Several studies have shown that memantine can significantly correct the binge-like eating behavior in human and animal models. People with overeating behav...
Main Authors: | Shi-Ning Deng, Yu-Hua Yan, Tai-Lin Zhu, Bing-Ke Ma, Hui-Ran Fan, Yan-Mei Liu, Wei-Guang Li, Fei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2019.00015/full |
Similar Items
-
Long-term NMDAR antagonism correlates reduced astrocytic glutamate uptake with anxiety-like phenotype
by: Eduardo R Zimmer, et al.
Published: (2015-06-01) -
Memantine: Reality and Potentiality
by: Rodolfo M. Antonello, et al.
Published: (2008-01-01) -
by: Rita Moretti, et al.
Published: (2008-05-01) -
Corrigendum: Long-term NMDAR antagonism correlates reduced astrocytic glutamate uptake with anxiety-like phenotype
by: Eduardo R Zimmer, et al.
Published: (2016-04-01) -
Evidence That Memantine Reduces Chronic Tinnitus Caused By Acoustic Trauma In Rats
by: Yiwen eZheng, et al.
Published: (2012-08-01)